Quantitative Investment Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-17,799
Closed -$137K 523
2025
Q3
$137K Buy
17,799
+5,114
+40% +$39.9K 0.02% 321
2025
Q2
$110K Buy
12,685
+2,338
+23% +$16.9K 0.01% 295
2025
Q1
$82K Buy
+10,347
New +$105K 0.01% 316
2024
Q3
Sell
-89,168
Closed -$872K 435
2024
Q2
$872K Buy
+89,168
New +$1.09M 0.1% 174
2023
Q3
Sell
-40,627
Closed -$1.03M 323
2023
Q2
$1.03M Buy
+40,627
New +$1.02M 0.1% 175
2022
Q4
Sell
-11,650
Closed -$295K 331
2022
Q3
$295K Sell
11,650
-35,070
-75% -$1.23M 0.05% 242
2022
Q2
$1.55M Buy
46,720
+26,530
+131% +$1.13M 0.24% 99
2022
Q1
$1.46M Buy
+20,190
New +$1.45M 0.16% 74

Other funds holding TDOC

Quantitative Investment Management's TDOC Position: Q4 2025 in Review

Quantitative Investment Management sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 17,799 shares — an estimated $137K sold.

Quantitative Investment Management first reported a position in TDOC in Q1 2022 and held it in 8 quarters. The position peaked at $1.55M in Q2 2022. 344 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • Quantitative Investment Management reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
  • Quantitative Investment Management sold 17,799 Teladoc Health shares in Q4 2025, an estimated $137K.
  • Quantitative Investment Management first reported a position in Teladoc Health in Q1 2022 and held it in 8 quarters.
  • Quantitative Investment Management's Teladoc Health position peaked at $1.55M in Q2 2022.
  • 344 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on Quantitative Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.